Mingxing Teng, Ph.D.
Affiliations: | 2022- | Baylor College of Medicine, Houston, TX |
Area:
Chemical Biology, Medicinal Chemistry, Synthetic ChemistryGoogle:
"Mingxing Teng"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Dawei Ma | grad student | 2010-2015 | SIOC,CAS |
| Martin Matzuk | post-doc | 2017-2018 | Baylor College of Medicine |
| Nathanael Gray | post-doc | 2018-2022 | Dana-Farber Cancer Institute, Harvard Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hassan MM, Li YD, Ma MW, et al. (2023) Exploration of the Tunability of BRD4 Degradation by DCAF16 -labelling Covalent Glues. Biorxiv : the Preprint Server For Biology |
| Teng M, Gray NS. (2023) The rise of degrader drugs. Cell Chemical Biology. 30: 864-878 |
| Teng M, Jiang J, Wang ES, et al. (2023) Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader. Angewandte Chemie (International Ed. in English). e202302364 |
| Li YD, Ma MW, Hassan MM, et al. (2023) Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degraders. Biorxiv : the Preprint Server For Biology |
| Teng M, Young DW, Tan Z. (2022) The Pursuit of Enzyme Activation: A Snapshot of the Gold Rush. Journal of Medicinal Chemistry |
| Ye Q, Belabed H, Wang Y, et al. (2022) Advancing ASMS with LC-MS/MS for the discovery of novel PDCL2 ligands from DNA-Encoded chemical library selections. Andrology |
| Modukuri RK, Yu Z, Tan Z, et al. (2022) Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections. Proceedings of the National Academy of Sciences of the United States of America. 119: e2122506119 |
| Teng M, Luskin MR, Cowan-Jacob SW, et al. (2022) The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug. Journal of Medicinal Chemistry |
| Teng M, Lu W, Donovan KA, et al. (2021) Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216. Journal of Medicinal Chemistry |
| Vervoort SJ, Devlin JR, Kwiatkowski N, et al. (2021) Targeting transcription cycles in cancer. Nature Reviews. Cancer. 22: 5-24 |